Objective:
To evaluate the effectiveness of the SEE program in improving medication adherence and reducing glaucoma-related distress compared to standard education.
Key Findings:
- SEE group showed significantly higher electronically monitored adherence (77.6%) compared to controls (58.0%).
- 54.9% of SEE participants achieved at least 80% adherence versus 23.7% of controls.
- The intervention led to a significant reduction in glaucoma-related distress, particularly in emotional burden and regimen-related distress.
Interpretation:
The SEE program demonstrates that personalized, motivational interviewing-based coaching can effectively enhance medication adherence and alleviate distress in glaucoma patients.
Limitations:
- The study was limited to a specific population from two health systems, which may affect generalizability.
- Potential biases in self-reported adherence measures.
Conclusion:
The SEE program is a promising approach to improve adherence and reduce distress in glaucoma patients, warranting further evaluation in broader settings.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
